APXH Performance — APEX Healthcare ETF

Data updated: 2022-12-28

APXH returned −15.46% over one year to Oct 2022. Over one year the fund beat its Emerging Markets Health Care Equity category average: $100 grew to $85, against $85 for the category. Volatility over the past 12 months was 20.32% a year. In the 12 months to Oct 2022 the fund took in a net $6.6M, and assets reached $6.43M.

APXH Growth of $100

What $100 invested in APEX Healthcare ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Health Care Equity category average over the same months.

PeriodAPXHCategory average
1 year (Nov 2021 – Oct 2022)$85$85
Since data start (Aug 2021 – Oct 2022)$87$87

APXH Trailing Returns

Total returns to Oct 2022, from SEC N-PORT.

PeriodTotal return
1 year−15.46%

APXH Annual Returns

Calendar-year total returns of APEX Healthcare ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2022 (Jan–Oct)−18.77%
2021 (Aug–Dec)+7.14%

APXH Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2022−10.8%−1.8%+4.7%−8.1%+1.7%−4.0%+5.2%−8.2%−4.1%+6.4%——
2021———————0.0%0.0%+2.9%−0.2%+4.3%

APXH Risk

Risk measures from monthly returns over Nov 2021 – Oct 2022.

  • 1-year volatility (annualised): 20.32%
  • Best month: +6.41% (Oct 2022)
  • Worst month: −10.76% (Jan 2022)

APXH Fund Flows

Monthly money in and out of APEX Healthcare ETF, from SEC Form N-PORT.

  • 12-month net flow: $6.6M
  • 12-month gross sales (incl. reinvestments): $6.6M
MonthSalesRedemptionsNet flow
Oct 2022$0$0$0
Sep 2022$0$0$0
Aug 2022$212K$0$212K
Jul 2022$0$0$0
Jun 2022$396K$0$396K
May 2022$212K$0$212K
Apr 2022$224K$0$224K
Mar 2022$447K$0$447K
Feb 2022$0$0$0
Jan 2022$2.9M$0$2.9M
Dec 2021$2.2M$0$2.2M
Nov 2021$0$0$0

APXH Assets Under Management

Net assets of APEX Healthcare ETF by report date, from SEC N-PORT filings.

Report dateNet assets
2022-10-31$6.43M
2022-07-31$6.64M
2022-04-30$5.82M
2022-01-31$5.47M
2021-10-31$491.05K

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.